Evidence map›Paper›PMID 22440888›Full record

ReviewCardiovascular research2012

Cardioprotection during cardiac surgery.

Derek J Hausenloy, Edney Boston-Griffiths, Derek M Yellon

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Cardiovascular research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02471001 (Coronary Sinus Blood Isoflurane Concentration in Patients Undergoing Heart Surgery), which is not on this map. Cited by 58 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 2 pooled it
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02471001 completednot on this mapstarted 2015, after this paper: background citation

Coronary Sinus Blood Isoflurane Concentration in Patients Undergoing Heart Surgery

TypeobservationalSponsorUniversity of EdinburghRan2015 to 2016Enrolled23ConditionsCardiac SurgeryArmsBlood samples
3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 2 syntheses or guidelines pooled it, 151 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Cardioprotection in cardiovascular surgery.Basic research in cardiology · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Derek J HausenloyThe Hatter Cardiovascular Institute, University College, London WC1E 6HX, UK.
Edney Boston-Griffiths
Derek M Yellon
University College London · GB

Funding

British Heart Foundation RG/03/007
6 · The paper itself

Abstract

Coronary heart disease (CHD) is the leading cause of morbidity and mortality worldwide. For a large number of patients with CHD, coronary artery bypass graft (CABG) surgery remains the preferred strategy for coronary revascularization. Over the last 10 years, the number of high-risk patients undergoing CABG surgery has increased significantly, resulting in worse clinical outcomes in this patient group. This appears to be related to the ageing population, increased co-morbidities (such as diabetes, obesity, hypertension, stroke), concomitant valve disease, and advances in percutaneous coronary intervention which have resulted in patients with more complex coronary artery disease undergoing surgery. These high-risk patients are more susceptible to peri-operative myocardial injury and infarction (PMI), a major cause of which is acute global ischaemia/reperfusion injury arising from inadequate myocardial protection during CABG surgery. Therefore, novel therapeutic strategies are required to protect the heart in this high-risk patient group. In this article, we review the aetiology of PMI during CABG surgery, its diagnosis and clinical significance, and the endogenous and pharmacological therapeutic strategies available for preventing it. By improving cardioprotection during CABG surgery, we may be able to reduce PMI, preserve left ventricular systolic function, and reduce morbidity and mortality in these high-risk patients with CHD.

Indexed as

Coronary Artery BypassCardiotonic AgentsCoronary Artery DiseaseHumansIschemic PostconditioningIschemic Preconditioning, MyocardialMyocardial InfarctionPostoperative ComplicationsReperfusion InjuryCardiotonic Agents

Identifiers

PMID22440888
PMCPMC3331616
OpenAlexW2061255722

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.